Why BRCA mutations are not tumour-agnostic biomarkers for PARP inhibitor therapy
| Errataetall: |
CommentOn: Nature. 2019 Jul;571(7766):576-579. - PMID 31292550 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Nature reviews. Clinical oncology - 16(2019), 12 vom: 03. Dez., Seite 725-726 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Curtin, Nicola J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
BRCA1 Protein |
|---|
| Anmerkungen: |
Date Completed 19.02.2020 Date Revised 20.04.2022 published: Print CommentOn: Nature. 2019 Jul;571(7766):576-579. - PMID 31292550 Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41571-019-0285-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM301900418 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM301900418 | ||
| 003 | DE-627 | ||
| 005 | 20231225105602.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41571-019-0285-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1006.xml |
| 035 | |a (DE-627)NLM301900418 | ||
| 035 | |a (NLM)31582817 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Curtin, Nicola J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Why BRCA mutations are not tumour-agnostic biomarkers for PARP inhibitor therapy |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.02.2020 | ||
| 500 | |a Date Revised 20.04.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Nature. 2019 Jul;571(7766):576-579. - PMID 31292550 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a BRCA1 Protein |2 NLM | |
| 650 | 7 | |a BRCA2 Protein |2 NLM | |
| 650 | 7 | |a Biomarkers, Tumor |2 NLM | |
| 650 | 7 | |a Poly(ADP-ribose) Polymerase Inhibitors |2 NLM | |
| 700 | 1 | |a Drew, Yvette |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma-Saha, Sweta |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature reviews. Clinical oncology |d 2009 |g 16(2019), 12 vom: 03. Dez., Seite 725-726 |w (DE-627)NLM187524599 |x 1759-4782 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2019 |g number:12 |g day:03 |g month:12 |g pages:725-726 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41571-019-0285-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2019 |e 12 |b 03 |c 12 |h 725-726 | ||